Rare tumors: Opportunities and challenges from the Children’s Oncology Group perspective
While all childhood cancers are rare, tumors that are particularly infrequent or underrepresented within pediatrics are studied under the umbrella of the Children’s Oncology Group Rare Tumor committee, divided into the Retinoblastoma and Infrequent Tumor subcommittees. The Infrequent Tumor subcommit...
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-12-01
|
| Series: | EJC Paediatric Oncology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772610X23000223 |
| _version_ | 1827373828665245696 |
|---|---|
| author | Kris Ann P. Schultz Murali Chintagumpala Jin Piao Kenneth S. Chen Rachana Shah Robyn D. Gartrell Emily Christison-Lagay Farzana Pashnakar Jesse L. Berry Allison F. O’Neill Lauren M. Vasta Ashley Flynn Sarah G. Mitchell Brittani KN. Seynnaeve Jeremy Rosenblum Samara L. Potter Junne Kamihara Carlos Rodriguez-Galindo Douglas S. Hawkins Theodore W. Laetsch |
| author_facet | Kris Ann P. Schultz Murali Chintagumpala Jin Piao Kenneth S. Chen Rachana Shah Robyn D. Gartrell Emily Christison-Lagay Farzana Pashnakar Jesse L. Berry Allison F. O’Neill Lauren M. Vasta Ashley Flynn Sarah G. Mitchell Brittani KN. Seynnaeve Jeremy Rosenblum Samara L. Potter Junne Kamihara Carlos Rodriguez-Galindo Douglas S. Hawkins Theodore W. Laetsch |
| author_sort | Kris Ann P. Schultz |
| collection | DOAJ |
| description | While all childhood cancers are rare, tumors that are particularly infrequent or underrepresented within pediatrics are studied under the umbrella of the Children’s Oncology Group Rare Tumor committee, divided into the Retinoblastoma and Infrequent Tumor subcommittees. The Infrequent Tumor subcommittee has traditionally included an emphasis on globally rare tumors such as adrenocortical carcinoma, nasopharyngeal carcinoma, or those tumors that are rare in young children, despite being common in adolescents and young adults, such as colorectal carcinoma, thyroid carcinoma, and melanoma. Pleuropulmonary blastoma, gonadal stromal tumors, pancreatic tumors including pancreatoblastoma, gastrointestinal stromal tumor, nonmelanoma skin cancers, neuroendocrine tumors, and desmoplastic small round cell tumors, as well as other carcinomas are also included under the heading of the Children’s Oncology Group Rare Tumor committee. While substantial challenges exist in rare cancers, inclusion and global collaboration remain key priorities to ensure high quality research to advance care. |
| first_indexed | 2024-03-08T11:23:24Z |
| format | Article |
| id | doaj.art-1d78ae7efc7f48d693fb7d9771fddd5b |
| institution | Directory Open Access Journal |
| issn | 2772-610X |
| language | English |
| last_indexed | 2024-03-08T11:23:24Z |
| publishDate | 2023-12-01 |
| publisher | Elsevier |
| record_format | Article |
| series | EJC Paediatric Oncology |
| spelling | doaj.art-1d78ae7efc7f48d693fb7d9771fddd5b2024-01-26T05:38:38ZengElsevierEJC Paediatric Oncology2772-610X2023-12-012100024Rare tumors: Opportunities and challenges from the Children’s Oncology Group perspectiveKris Ann P. Schultz0Murali Chintagumpala1Jin Piao2Kenneth S. Chen3Rachana Shah4Robyn D. Gartrell5Emily Christison-Lagay6Farzana Pashnakar7Jesse L. Berry8Allison F. O’Neill9Lauren M. Vasta10Ashley Flynn11Sarah G. Mitchell12Brittani KN. Seynnaeve13Jeremy Rosenblum14Samara L. Potter15Junne Kamihara16Carlos Rodriguez-Galindo17Douglas S. Hawkins18Theodore W. Laetsch19Cancer and Blood Disorders, Children’s Minnesota, Minneapolis, MN, USA; Correspondence to: Cancer and Blood Disorders, Children’s Minnesota, 2530 Chicago Avenue South, Minneapolis, MN 55404, USA.Division of Hematology-Oncology, Department of Pediatrics, Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX, USAUniversity of Southern California Keck School of Medicine, Los Angeles, CA, USADepartment of Pediatrics, UT Southwestern Medical Center, Dallas, TX, USAUniversity of Southern California Keck School of Medicine, Los Angeles, CA, USA; Division of Hematology-Oncology, Department of Pediatrics, Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, CA, USADivision of Pediatric Hematology/Oncology, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY, USAYale School of Medicine, Yale New-Haven Children’s Hospital, New Haven, CT, USADepartment of Pediatrics, Yale University School of Medicine, New Haven, CT, USAUniversity of Southern California Keck School of Medicine, Los Angeles, CA, USA; The Vision Center, Children's Hospital Los Angeles, The Saban Research Institute, Children's Hospital Los Angeles, USC Roski Eye Institute, Norris Comprehensive Cancer Center, Los Angeles, CA, USADana-Farber Cancer Institute/Boston Children’s Cancer and Blood Disorders Center and Harvard Medical School, Department of Pediatric Oncology, Boston, MA, USADepartment of Pediatrics, Walter Reed National Military Medical Center, Bethesda, MD, USAHematology/Oncology, Children’s Mercy Kansas City, Kansas City, MO, USAAflac Cancer & Blood Disorders Center, Children’s Healthcare of Atlanta, Atlanta, GA, USA; Department of Pediatrics, Emory University, Atlanta, GA, USADepartment of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USADepartment of Pediatrics, Division of Pediatric Hematology/Oncology, Westchester Medical Center, New York Medical College, Valhalla, New York, NY, USAThe Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children’s Hospital, Columbus, OH, USA; Department of Pediatrics, The Ohio State University, Columbus, OH, USADana-Farber Cancer Institute/Boston Children’s Cancer and Blood Disorders Center and Harvard Medical School, Department of Pediatric Oncology, Boston, MA, USADepartments of Global Pediatric Medicine and Oncology, St. Jude Children’s Research Hospital, Memphis, TN, USADivision of Hematology-Oncology, Seattle Children's Hospital, University of Washington, Seattle, WA, USADivision of Oncology, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, USAWhile all childhood cancers are rare, tumors that are particularly infrequent or underrepresented within pediatrics are studied under the umbrella of the Children’s Oncology Group Rare Tumor committee, divided into the Retinoblastoma and Infrequent Tumor subcommittees. The Infrequent Tumor subcommittee has traditionally included an emphasis on globally rare tumors such as adrenocortical carcinoma, nasopharyngeal carcinoma, or those tumors that are rare in young children, despite being common in adolescents and young adults, such as colorectal carcinoma, thyroid carcinoma, and melanoma. Pleuropulmonary blastoma, gonadal stromal tumors, pancreatic tumors including pancreatoblastoma, gastrointestinal stromal tumor, nonmelanoma skin cancers, neuroendocrine tumors, and desmoplastic small round cell tumors, as well as other carcinomas are also included under the heading of the Children’s Oncology Group Rare Tumor committee. While substantial challenges exist in rare cancers, inclusion and global collaboration remain key priorities to ensure high quality research to advance care.http://www.sciencedirect.com/science/article/pii/S2772610X23000223Rare cancerRare tumorNasopharyngeal carcinomaAdrenocortical carcinomaPleuropulmonary blastomaRetinoblastoma |
| spellingShingle | Kris Ann P. Schultz Murali Chintagumpala Jin Piao Kenneth S. Chen Rachana Shah Robyn D. Gartrell Emily Christison-Lagay Farzana Pashnakar Jesse L. Berry Allison F. O’Neill Lauren M. Vasta Ashley Flynn Sarah G. Mitchell Brittani KN. Seynnaeve Jeremy Rosenblum Samara L. Potter Junne Kamihara Carlos Rodriguez-Galindo Douglas S. Hawkins Theodore W. Laetsch Rare tumors: Opportunities and challenges from the Children’s Oncology Group perspective EJC Paediatric Oncology Rare cancer Rare tumor Nasopharyngeal carcinoma Adrenocortical carcinoma Pleuropulmonary blastoma Retinoblastoma |
| title | Rare tumors: Opportunities and challenges from the Children’s Oncology Group perspective |
| title_full | Rare tumors: Opportunities and challenges from the Children’s Oncology Group perspective |
| title_fullStr | Rare tumors: Opportunities and challenges from the Children’s Oncology Group perspective |
| title_full_unstemmed | Rare tumors: Opportunities and challenges from the Children’s Oncology Group perspective |
| title_short | Rare tumors: Opportunities and challenges from the Children’s Oncology Group perspective |
| title_sort | rare tumors opportunities and challenges from the children s oncology group perspective |
| topic | Rare cancer Rare tumor Nasopharyngeal carcinoma Adrenocortical carcinoma Pleuropulmonary blastoma Retinoblastoma |
| url | http://www.sciencedirect.com/science/article/pii/S2772610X23000223 |
| work_keys_str_mv | AT krisannpschultz raretumorsopportunitiesandchallengesfromthechildrensoncologygroupperspective AT muralichintagumpala raretumorsopportunitiesandchallengesfromthechildrensoncologygroupperspective AT jinpiao raretumorsopportunitiesandchallengesfromthechildrensoncologygroupperspective AT kennethschen raretumorsopportunitiesandchallengesfromthechildrensoncologygroupperspective AT rachanashah raretumorsopportunitiesandchallengesfromthechildrensoncologygroupperspective AT robyndgartrell raretumorsopportunitiesandchallengesfromthechildrensoncologygroupperspective AT emilychristisonlagay raretumorsopportunitiesandchallengesfromthechildrensoncologygroupperspective AT farzanapashnakar raretumorsopportunitiesandchallengesfromthechildrensoncologygroupperspective AT jesselberry raretumorsopportunitiesandchallengesfromthechildrensoncologygroupperspective AT allisonfoneill raretumorsopportunitiesandchallengesfromthechildrensoncologygroupperspective AT laurenmvasta raretumorsopportunitiesandchallengesfromthechildrensoncologygroupperspective AT ashleyflynn raretumorsopportunitiesandchallengesfromthechildrensoncologygroupperspective AT sarahgmitchell raretumorsopportunitiesandchallengesfromthechildrensoncologygroupperspective AT brittaniknseynnaeve raretumorsopportunitiesandchallengesfromthechildrensoncologygroupperspective AT jeremyrosenblum raretumorsopportunitiesandchallengesfromthechildrensoncologygroupperspective AT samaralpotter raretumorsopportunitiesandchallengesfromthechildrensoncologygroupperspective AT junnekamihara raretumorsopportunitiesandchallengesfromthechildrensoncologygroupperspective AT carlosrodriguezgalindo raretumorsopportunitiesandchallengesfromthechildrensoncologygroupperspective AT douglasshawkins raretumorsopportunitiesandchallengesfromthechildrensoncologygroupperspective AT theodorewlaetsch raretumorsopportunitiesandchallengesfromthechildrensoncologygroupperspective |